Loading clinical trials...
Loading clinical trials...
Treatment of tauopathies such as Progressive Supranuclear Palsy (PSP) and Cortico Basal Degeneration (CBD) remains a major challenge. These rare severe neurodegenerative extrapyramidal movement disord...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
NCT05121012 · Multiple System Atrophy, Progressive Supranuclear Palsy (PSP)
NCT04715399 · Frontotemporal Degeneration(FTD), Primary Progressive Aphasia(PPA), and more
NCT07136844 · Neuromuscular Diseases, Obesity (Disorder), and more
NCT03174938 · Dementia, Alzheimer Disease, and more
NCT06162013 · Progressive Supranuclear Palsy, Multiple System Atrophy, and more
Hôpital Fondation Adolphe de Rothschild
Paris, Île-de-France Region
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions